ALGS — Aligos Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapMomentum Trap

Annual balance sheet for Aligos Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	118	244	191	126	136
Total Other Current Assets
Total Current Assets	120	250	204	134	141
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	16.1	14.9	15	12.5	9.82
Long Term Investments
Other Long Term Assets
Total Assets	147	265	235	147	152
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	13.8	30.3	39	33.1	23.9
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	29.3	45.3	50.6	42.8	59.4
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	117	220	185	104	92.1
Total Liabilities & Shareholders' Equity	147	265	235	147	152
Total Common Shares Outstanding